Changing Perceptions About the Dermatology Residency Application Process Among Applicants and Program Directors: 2020-2022.

covid19 dermatology diversity and equity in medicine medical education residency and internship

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Apr 2024
Historique:
accepted: 06 04 2024
medline: 10 5 2024
pubmed: 10 5 2024
entrez: 10 5 2024
Statut: epublish

Résumé

Importance Over the last two years, dermatology has undergone significant reforms in the residency application process in efforts to reduce applicant stress, increase equity, and due to the COVID-19 pandemic.  Objective We aimed to determine applicant and program director (PD) perspectives in implementing these changes over the last two application cycles.  Design, setting, and participants Anonymous online surveys were administered by the Association of American Medical Colleges (AAMC) to PDs and applicants from the 2021-2022 dermatology residency application cycle. These results were compared with similar online surveys distributed after the 2020-2021 cycle. Results Coordinated interview release was introduced in the 2020-2021 dermatology application cycle. At that time, 57% of PDs and 84% of applicants wished that more programs participated in the release, compared to 53% and 84%, respectively, in the 2021-2022 cycle. In 2021, 28% of PDs reported matching applicants from their home institution higher on their list compared to 14% in 2022. In 2021 and 2022, 94% of PDs reported that diversity was an explicit goal in their application process. However, in 2021, 33% of PDs reported that they matched no UIMs (underrepresented in medicine) in their cohort, which grew to 39% in 2022. Conclusions This study identifies key trends in applicant and PD perspectives associated with changes in the application process such as coordinated interview release, virtual interviews, and emphasis on diversity. Additional data is needed from subsequent cycles in order to determine the efficacy of these reforms.

Identifiants

pubmed: 38725733
doi: 10.7759/cureus.57864
pmc: PMC11078589
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e57864

Informations de copyright

Copyright © 2024, Rinderknecht et al.

Déclaration de conflit d'intérêts

Drs. Rosenblatt, Rosman, Worswick and Ahmed are on the Association of Professors of Dermatology Residency Program Directors Section Steering Committee. Otherwise, no COI to report.

Auteurs

Fatuma-Ayaan B Rinderknecht (FB)

Dermatology, University of California San Francisco School of Medicine, San Francisco, USA.

Kandice C Bailey (KC)

Dermatology, Washington University School of Medicine, St. Louis, USA.

Danielle E Novack (DE)

Dermatology, Icahn School of Medicine at Mount Sinai, New York, USA.

Adena E Rosenblatt (AE)

Dermatology, University of Chicago Medical Center, Chicago, USA.

Dana Dunleavy (D)

Medical Education, Association of American Medical Colleges, Washington DC, USA.

Bobby D Naemi (BD)

Medical Education, Association of American Medical Colleges, Washington DC, USA.

Ilana S Rosman (IS)

Dermatology, Washington University School of Medicine, St. Louis, USA.

Ammar Ahmed (A)

Dermatology, Dell Medical School - The University of Texas, Austin, USA.

Scott Worswick (S)

Dermatology, University of Southern California Keck School of Medicine, Los Angeles, USA.

Classifications MeSH